Severe cholestasis due to disseminated histoplasmosis under adalimumab-containing immunosuppressive therapy

Berend J van Welzen; Karel J van Erpecum; Pieter-Jan A Haas; Fiebo J ten Kate; Tania Mudrikova

doi:10.1016/j.clinre.2013.03.008

Severe cholestasis due to disseminated histoplasmosis under adalimumab-containing immunosuppressive therapy

Berend J van Welzen
, Karel J van Erpecum
, Pieter-Jan A Haas
, Fiebo J ten Kate
, Tania Mudrikova

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	e105-e107
Number of pages	3
Journal	Clinics and Research in Hepatology and Gastroenterology
Volume	37
Issue number	4
DOIs	https://doi.org/10.1016/j.clinre.2013.03.008
Publication status	Published - Sept 2013

Keywords

Adalimumab
Aged
Anti-Inflammatory Agents/adverse effects
Antibodies, Monoclonal, Humanized/adverse effects
Cholestasis/chemically induced
Female
Histoplasmosis/complications
Humans
Immunosuppression
Immunosuppressive Agents/adverse effects
Severity of Illness Index

Access to Document

10.1016/j.clinre.2013.03.008

http://www.ncbi.nlm.nih.gov/pubmed/23663920

Cite this

@article{ac259d735c27498bb4ae2f1392a3e158,

title = "Severe cholestasis due to disseminated histoplasmosis under adalimumab-containing immunosuppressive therapy",

keywords = "Adalimumab, Aged, Anti-Inflammatory Agents/adverse effects, Antibodies, Monoclonal, Humanized/adverse effects, Cholestasis/chemically induced, Female, Histoplasmosis/complications, Humans, Immunosuppression, Immunosuppressive Agents/adverse effects, Severity of Illness Index",

author = "\{van Welzen\}, \{Berend J\} and \{van Erpecum\}, \{Karel J\} and Haas, \{Pieter-Jan A\} and \{ten Kate\}, \{Fiebo J\} and Tania Mudrikova",

year = "2013",

month = sep,

doi = "10.1016/j.clinre.2013.03.008",

language = "English",

volume = "37",

pages = "e105--e107",

journal = "Clinics and Research in Hepatology and Gastroenterology",

issn = "2210-7401",

publisher = "Elsevier Masson",

number = "4",

}

TY - JOUR

T1 - Severe cholestasis due to disseminated histoplasmosis under adalimumab-containing immunosuppressive therapy

AU - van Welzen, Berend J

AU - van Erpecum, Karel J

AU - Haas, Pieter-Jan A

AU - ten Kate, Fiebo J

AU - Mudrikova, Tania

PY - 2013/9

Y1 - 2013/9

KW - Adalimumab

KW - Aged

KW - Anti-Inflammatory Agents/adverse effects

KW - Antibodies, Monoclonal, Humanized/adverse effects

KW - Cholestasis/chemically induced

KW - Female

KW - Histoplasmosis/complications

KW - Humans

KW - Immunosuppression

KW - Immunosuppressive Agents/adverse effects

KW - Severity of Illness Index

U2 - 10.1016/j.clinre.2013.03.008

DO - 10.1016/j.clinre.2013.03.008

M3 - Article

C2 - 23663920

SN - 2210-7401

VL - 37

SP - e105-e107

JO - Clinics and Research in Hepatology and Gastroenterology

JF - Clinics and Research in Hepatology and Gastroenterology

IS - 4

ER -